article Related Topics:
Rifapentine
 

Rifapentine (marketed under the brand name Priftin by Aventis) is an antibiotic drug used in the treatment of tuberculosis.

History


Rifapentin was first synthesized in 1965 by the same company that produced rifampin. The drug was approved by the Food and Drug Administration (FDA) in June 1998.

Rifamycin antibiotics

 

This article is licensed under the GNU Free Documentation License. It uses material from the "Rifapentine".

Home Pageartsbusinesscomputersgameshealthhospitalshomekids & teensnewsphysiciansrecreationreferenceregionalscienceshoppingsocietysportsworld